Who
Eduardo Alfonso
Director
Company insider
Files Form 4 as: Director, Bausch + Lomb.
In numbers
- Trades disclosed
- 10
- Buys
- 1
- Sells
- 0
- Bought
- $154K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 19 Feb 2026
- Last trade
- 26 May 2026
- Last filed
- 28 May 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 May 2026filed 28 May 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | $250K15,842 at $15.78 | filing |
| 26 May 2026filed 28 May 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | $250K15,842 at $15.78 | filing |
| 30 Apr 2026filed 1 May 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | $22K1,375 at $15.90 | filing |
| 30 Apr 2026filed 1 May 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | $22K1,375 at $15.90 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Bought | $77K4,300 at $17.90 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —4,300 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Bought | $77K4,300 at $17.90 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —4,300 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —5,255 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —5,255 at $0.00 | filing |
News
Verily Health, Bausch + Lomb partner to bring dry eye care to appBLCO · healio.com · 15 Oct 2026Bausch + Lomb (NYSE:BLCO) Stock Price Down 5.8% – Here's What HappenedBLCO · dailypolitical.com · 14 Oct 2026Barclays Upgrades Bausch + Lomb (NYSE:BLCO) to "Strong-Buy"BLCO · dailypolitical.com · 9 Oct 2026
0 headlines in the last 90 days name Eduardo Alfonso; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.